Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri Trudeau

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Clinical Transplantation|January 18, 2022
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol-related liver diseaseRanya Selim, Yueren Zhou, Loralee B Rupp, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Journal of Viral Hepatitis|March 5, 2023
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antiviralsRanya Selim, Stuart C Gordon, Yueren Zhou, et al.
Transplantation|February 27, 2024
Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory DeathKatsunori Miyake, Lucy C Chau, Sheri Trudeau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)Stuart C Gordon, Eyasu H Teshale, Philip R Spradling, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016)Mei Lu, Jia Li, Yueren Zhou, et al.
Journal of Viral Hepatitis|June 15, 2019
Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failureMei Lu, Kuan-Han Wu, Jia Li, et al.
Journal of Clinical Gastroenterology|July 25, 2017
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United StatesStuart C Gordon, Sheri Trudeau, Jia Li, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Transplantation|January 18, 2022
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol-related liver diseaseRanya Selim, Yueren Zhou, Loralee B Rupp, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Journal of Viral Hepatitis|March 5, 2023
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antiviralsRanya Selim, Stuart C Gordon, Yueren Zhou, et al.
Transplantation|February 27, 2024
Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory DeathKatsunori Miyake, Lucy C Chau, Sheri Trudeau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)Stuart C Gordon, Eyasu H Teshale, Philip R Spradling, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016)Mei Lu, Jia Li, Yueren Zhou, et al.
Journal of Viral Hepatitis|June 15, 2019
Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failureMei Lu, Kuan-Han Wu, Jia Li, et al.
Journal of Clinical Gastroenterology|July 25, 2017
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United StatesStuart C Gordon, Sheri Trudeau, Jia Li, et al.
Pageof 7